Dr. Kevin Bainey, Director of the CVC ECG Core Laboratory, was featured on multiple news outlets discussing key results from the recent publication Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction in Clinical Practice: Insights From the Vital Heart Response Registry. This publication was also coauthored by several other members of the […]
Congratulations to Drs. Ana Savu, Linn Moore and Padma Kaul, along with their fellow coauthors, on the publication of their article Elevated fasting vs post-load glucose levels and pregnancy outcomes in gestational diabetes: a population-based study in Diabetic Medicine. It is known that women with gestational diabetes mellitus (GDM) are at an increased risk of […]
On November 18th it was announced that the Phase 3 VICTORIA study evaluating the efficacy and safety of vericiguat, a soluble guanylate cyclase (sGC) stimulator being developed to treat patients with worsening chronic heart failure, has met the primary efficacy endpoint. Vericiguat reduced the risk of the composite endpoint of heart failure hospitalization or cardiovascular […]
The CVC has officially moved! Our new offices are located at the following address: 4-120 Katz Group Centre for Pharmacy and Health ResearchUniversity of AlbertaEdmonton, AB T6G 2E1 Visit our contact page to view our new building location on Google Maps.
On behalf of the Canadian VIGOUR Centre (CVC) and the Beyond 2018 (B2K18) educational program, we are pleased to share a Canadian Cardiovascular Society-accredited webinar series initiative that is being provided as an extension to the B2K18 symposium (held annually during the Canadian Cardiovascular Congress, most recently October 22, 2018). The 5th webinar in this […]
We are pleased to share the 2018 Canadian VIGOUR Centre (CVC) Annual Report. This year’s report highlights the results of our organization’s focus in 2018 and emphasizes our continuing commitment to enhancing human health through innovation and training the next generation of health researchers. Our staff and faculty have all contributed to this compendium and […]
We are pleased to share with you the Spring 2019 issue of the Canadian Cardiac Chronicle. This issue features: A letter from CVC Co-Director, Justin Ezekowitz, considering the complexity of clinical research, and the importance of providing sophisticated answers to simple questions Recent updates from current and upcoming clinical trials An overview of key ideas […]
On behalf of the Canadian VIGOUR Centre (CVC) and the Beyond 2018 (B2K18) educational program, we are pleased to share a Canadian Cardiovascular Society-accredited webinar series initiative that is being provided as an extension to the B2K18 symposium (held annually during the Canadian Cardiovascular Congress, most recently October 22, 2018). The 4th webinar in this […]
On behalf of the Canadian VIGOUR Centre (CVC) and the Beyond 2018 (B2K18) educational program, we are pleased to share a Canadian Cardiovascular Society-accredited webinar series initiative that is being provided as an extension to the B2K18 symposium (held annually during the Canadian Cardiovascular Congress, most recently October 22, 2018). The 3rd webinar in this […]
On behalf of the Canadian VIGOUR Centre (CVC) and the Beyond 2018 (B2K18) educational program, we are pleased to share a Canadian Cardiovascular Society-accredited webinar series initiative that is being provided as an extension to the B2K18 symposium (held annually during the Canadian Cardiovascular Congress, most recently October 22, 2018). The second webinar in this […]
We are pleased to share with you the Winter 2018 issue of the Canadian Cardiac Chronicle. This issue features: A letter from Founding Director Dr. Paul W. Armstrong on the importance of reliable research and scientific literacy Recent updates from current and upcoming clinical trials Information about upcoming 2019 events, including ACC Rockies,the CVC Clinical […]
The CVC is pleased to announce the addition of two new associate faculty members. Dr. Sean McMurtry is a clinician scientist and Associate Professor in the Division of Cardiology. Dr. McMurtry is engaged in basic and clinical research projects studying coronary artery disease, peripheral artery disease, venous thromboembolism, and thoracic aortic disease. Dr. Roopinder Sandhu […]
On behalf of the Canadian VIGOUR Centre (CVC) and the Beyond 2018 (B2K18) educational program, we are pleased to share a Canadian Cardiovascular Society-accredited webinar series initiative that is being provided as an extension to the B2K18 symposium (held annually during the Canadian Cardiovascular Congress, most recently October 22, 2018). The first webinar in this […]
Congratulations to the ODYSSEY OUTCOMES team on the publication of Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome in The New England Journal of Medicine. The ODYSSEY OUTCOMES clinical trial sought to determine whether alirocumab, a fully human monoclonal antibody to proprotein convertase subtilisin–kexin type 9 (PCSK9), would improve cardiovascular outcomes after an acute coronary […]
The CVC is pleased to share that our organization’s Founding Director, Dr. Paul W. Armstrong, has been appointed as Chair of the Institute of Health Economics (IHE) Board of Directors, effective October 1, 2018. More information on this appointment can be found on the IHE’s website here (Photo: Richard Siemens ©️university of Alberta)
We are pleased to share with you the Summer 2018 issue of the Canadian Cardiac Chronicle. This issue features: A letter from Co-Director Shaun Goodman about patient-oriented research; Recent updates from current and upcoming clinical trials; An update on the ICH GCP E6 guidelines; An announcement about the CVC’s 2017 Annual Report Information about the […]
Congratulations to Dr. Kevin Bainey, who was featured in the Edmonton Journal, speaking to his recently published article “Population-level incidence and outcomes of myocardial infarction with non-obstructive coronary arteries (MINOCA): Insights from the Alberta contemporary acute coronary syndrome patients invasive treatment strategies (COAPT) study”, which was also coauthored by several other members of the CVC […]
We are pleased to share the 2017 CVC Annual Report. This year’s report highlights the results of our organization’s focus in 2017 and emphasizes our continuing commitment to enhancing human health through innovation and training the next generation of health researchers. Our staff and faculty have all contributed to this compendium and the elements contained […]
